Typhoid Fever and Travel: Why This Waterborne Illness Still Kills Thousands Each Year

Typhoid fever is one of those infections that sounds historical but remains an entirely current clinical concern for UK travellers. Caused by the bacterium Salmonella Typhi, it is a serious systemic illness responsible for an estimated 11 million cases and over 100,000 deaths globally each year. It is preventable through vaccination and food hygiene, but vaccine protection is partial, which makes understanding both the disease and its prevention genuinely important.

The infection remains endemic across South Asia, where the highest global burden falls. India, Pakistan, Nepal and Bangladesh together account for a substantial proportion of global typhoid cases. It is also prevalent across Southeast Asia, sub-Saharan Africa, Central America and parts of the Middle East. UK travellers visiting these regions, and particularly those visiting friends and relatives in South Asia, are among the most exposed groups in UK travel health surveillance data.

How Typhoid Fever Is Transmitted

Typhoid is transmitted exclusively through ingestion of food or water contaminated with human faeces containing Salmonella Typhi. Contaminated drinking water is the primary vehicle in endemic regions, particularly where sanitation infrastructure is poor. Food contaminated during preparation by an infected food handler is also a significant route. Unlike some gastrointestinal infections, hepatitis A being the closest parallel, typhoid cannot be acquired through respiratory contact.

The infectious dose for Salmonella Typhi is relatively low, meaning that small amounts of contamination are sufficient to establish infection. This is clinically relevant because travellers who are diligent about food and water hygiene can still be exposed in settings where contamination of apparently safe food and water is not visible.

Clinical Presentation and Complications

Typhoid fever has an incubation period of one to three weeks after ingestion of the organism. The initial presentation is a sustained, rising fever that typically reaches 39 to 40 degrees Celsius by the end of the first week. Associated symptoms include severe headache, malaise, abdominal pain and, importantly, a relative bradycardia, the heart rate is lower than would typically be expected for the degree of fever, a useful diagnostic clue.

In untreated cases, the second week is characterised by sustained fever, progressive abdominal distension and, in some patients, the appearance of rose-coloured spots (rose spots) on the trunk. Intestinal haemorrhage and intestinal perforation are the most serious complications of typhoid fever and carry significant mortality without surgical intervention. Hepatitis, myocarditis, pneumonia and neurological complications can also occur.

With appropriate antibiotic therapy, most patients recover, but treatment in endemic regions is complicated by a growing problem of antibiotic resistance. Extensively drug-resistant (XDR) Salmonella Typhi strains, resistant to multiple first-line antibiotics, have been documented particularly in Pakistan. This has significant implications for both treatment and the clinical argument for vaccination.

Typhoid Vaccination: What Is Available and Who Needs It

Two types of typhoid vaccine are available in the UK. The injectable typhoid vaccine, ViATIM (combination vaccination) or Typhim Vi, is a polysaccharide vaccine given as a single injection and provides protection for approximately three years. The oral typhoid vaccine, Vivotif, is a live attenuated vaccine taken as three capsules on alternate days (days 1, 3 and 5) and provides protection for approximately three years.

The oral vaccine is not suitable for patients who are immunosuppressed or taking antibiotics, and the capsules must be refrigerated and taken under specific instructions (including avoidance of warm liquid when swallowing). For most travellers, the injectable vaccine is the more straightforward clinical choice and is often given in combination with the hepatitis A vaccine as Hepatyrix or ViATIM.

Typhoid vaccine efficacy is approximately 50 to 80 percent, which is lower than many other vaccines. This means that vaccination provides significant but not complete protection, and food and water hygiene measures remain essential and complementary. The protection equation in typhoid is: vaccination plus hygiene, not vaccination instead of hygiene.

Food and Water Hygiene in Practice

The rule of thumb often cited in travel health consultations is ‘boil it, cook it, peel it or forget it.’ In practice this means: drinking only bottled water from sealed containers, or water that has been boiled or treated, avoiding ice in drinks, avoiding raw salads, unpeeled fruit and uncooked vegetables in endemic regions, choosing freshly cooked, piping-hot food from reputable sources, and maintaining rigorous hand hygiene before eating and after using the toilet.

These measures are not failsafe, but they meaningfully reduce exposure risk when applied consistently. Combined with typhoid vaccination, they represent the most effective available protection against this preventable illness.

This article is for general information and does not constitute individual clinical advice. Please book a travel health consultation at Halton Pharmacy, Leeds, before travelling to a typhoid-endemic region.